Ohr Pharmaceutical, Inc. (Nasdaq: OHRP) announced that it has entered into subscription agreements with institutional and accredited investors for the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE